Pharmacy Website
    Clinic Website

    Intelligence » Cholesterol » Last Week

    Subscribe to get latest posts via email or subscribe to a RSS feed.

    Becoming a “Triple-Goal Achiever”: Meeting Your A1C, Blood Pressure, and LDL Cholesterol Goals

    Monday, June 18, 2018 -- There are a lot of “numbers” to know and manage when you have diabetes. Learn how to meet your A1C, blood pressure, and LDL cholesterol goals... The post Becoming a “Triple-Goal Achiever”: Meeting Your A1C, Blood Pressure, and LDL Cholesterol Goals appeared first on Diabetes Self-Management.

    Individuals With Very High Levels of Lipoprotein(a) May Benefit Most From LDL(a)-Lowering Drugs

    Thursday, June 21, 2018 -- Dr. Stephen Burgess PhD Programme Leader at the Medical Research Council Biostatistics Unit University of Cambridge What is the background for this study? What are the main findings? Response: Lipoprotein(a) is a lipoprotein subclass, and an important biomarker for coronary heart disease. As a clinical biomarker, it has a similar story to LDL-cholesterol (“bad” cholesterol), in that it is thought to be a causal risk factor for coronary heart disease, and so is a potential target for drug development. However, while drugs that lower LDL-cholesterol, such as statins, have been successful in reducing coronary heart disease risk, drugs that lower lipoprotein(a) have not as yet been successful. New drugs are currently in development that specifically target lipoprotein(a) and

    The Bergamot fruit, more used for perfumes and Earl Grey tea, found to be a natural anti-cholesterol remedy

    Saturday, June 16, 2018 -- (Natural News) A study published in the Science Direct journal Bioenergetics found that the bergamot fruit, which is commonly used for perfumes and Earl Grey tea, can be a natural anti-cholesterol remedy. In conducting the study, a team of chemists at the University of Calabria in Italy collaborated with biologists at the University of Salford... Read More

    Fenofibrate Improves Cholesterol Levels in Type 2 Diabetes

    Wednesday, June 20, 2018 -- To understand the mechanism underlying the benefit of fenofibrate on vascular complications in patients with type 2 diabetes, investigators assessed carotid intima thickness as a marker of subclinical atherosclerosis.